Loading...

Reunion Neuroscience Inc.

REUN.TO•TSX
Healthcare
Biotechnology
CA$1.42
CA$-0.04(-2.74%)

Reunion Neuroscience Inc. (REUN.TO) Stock Overview

Explore Reunion Neuroscience Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap16.6M
P/E Ratio-0.34
EPS (TTM)$-3.30
ROE-1.10%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.38

REUN.TO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Reunion Neuroscience Inc. (REUN.TO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.38.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.34 and a market capitalization of 16.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-2.74%
3-Month Change
-5.96%
6-Month Change
1.43%
Year-to-Date (YTD) Change
2.16%
1-Year Change
-68.93%
3-Year Change
-89.48%
5-Year Change
-89.48%
All-Time (Max) Change
-89.48%

Contact Information

https://www.fieldtriphealth.com
30 Duncan Street, Toronto, ON, M5V 2C3

Company Facts

16 Employees
IPO DateOct 6, 2020
CountryCA

Frequently Asked Questions

;